Scleral buckling and vitrectomy combination is the most successful in retinal reattachment

Article

A combination of scleral buckling and vitrectomy produced better anatomical success rates and fewer operative procedures in surgery for primary retinal detachment patients.

A combination of scleral buckling and vitrectomy produced better anatomical success rates and fewer operative procedures in surgery for primary retinal detachment patients, according to a study published in Retina.

Dr Schaal Shlomit et al., Department of Ophthalmology and Visual Sciences, University of Louisville, Kentucky, USA, conducted a retrospective interventional comparative case series on 1226 primary retinal detachment patients. The patients were split in to 4 groups: 56 patients underwent pneumatic retinopexy surgery, 316 patients underwent both scleral buckling and vitrectomy surgery, 322 patients underwent scleral buckling surgery and 442 patients had pars plana vitrectomy surgery.

Outcome measures included reattachment success rates, pre- and postoperative visual acuity, complications, and change in refractive error. A 1-year follow-up was completed on all patients.

The results demonstrated an 86% initial success rate for scleral buckling only, 90% for vitrectomy only, 94% for scleral buckling and vitrectomy and 63% for pneumatic retinopexy surgery.

With exception of the pneumatic retinopexy group, there were no statistically significant differences between the other 3 groups. There were also no statistically significant differences in visual acuity between all of the groups.

Overall, the most successful techniques for the repair of primary rhegmatogenous retinal detachments are scleral buckling used in conjunction with vitrectomy, as well as scleral buckling only and vitrectomy only.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.